All lobbying filings

HOLLAND & KNIGHT LLP

HOLLAND & KNIGHT LLP filed a Q3 report for IPSEN BIOPHARMACEUTICALS, INC. on October 7, 2026, reporting $20,000 in lobbying income.

Lobbying for IPSEN BIOPHARMACEUTICALS, INC. · Biopharmaceutical Company

All filings by HOLLAND & KNIGHT LLP · Everything IPSEN BIOPHARMACEUTICALS, INC. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 7, 2026

Income

$20,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Taxation/Internal Revenue Code

Tax Reform - Restoring the Orphan Drug Tax Credit.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.